Plain-English translation of NCT07388407 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This research study is looking at how your genes influence your response to leflunomide, a medication used to treat rheumatoid arthritis. Researchers want to understand why some patients benefit from this treatment while others experience bothersome side effects or don't respond as well. By studying genetic variations in Pakistani patients, they hope to predict who will do best on the medication.
Many people taking this medication either stop because of side effects or don't get the relief they need. If doctors could predict ahead of time who will respond well and who might have problems, they could make better treatment choices earlier and help prevent lasting joint damage.
You likely qualify if…
You likely don't qualify if…
You would take leflunomide as prescribed by your doctor, and researchers would monitor how well it works for you and any side effects you experience. They will collect a blood sample to analyze your genes and compare it with your treatment response over time. Your participation would last at least three months while you continue your regular arthritis care.
AI-generated summary from trial data · Jun 20, 2026 · Not medical advice
Pakistan